Redwood Pharma AB reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported net loss was SEK 3.98 million compared to SEK 1.97 million a year ago. Basic loss per share from continuing operations was SEK 4 compared to SEK 9 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.9 SEK | -16.43% | +54.26% | -38.30% |
06-12 | Redwood Pharma Provides an Update on the Process for Divesting the Company's Assets | CI |
05-23 | Redwood Pharma Provides Update on Process to Divest Assets | CI |
1st Jan change | Capi. | |
---|---|---|
-38.30% | 730K | |
+15.72% | 77.46B | |
+13.65% | 8.94B | |
-24.30% | 4.28B | |
+12.79% | 4.18B | |
+10.97% | 2.23B | |
-30.57% | 2.06B | |
+8.99% | 1.97B | |
-45.76% | 1.69B | |
-0.50% | 1.64B |
- Stock Market
- Equities
- REDW Stock
- News Redwood Pharma AB
- Redwood Pharma AB Reports Earnings Results for the First Quarter Ended March 31, 2023